Works matching IS 09024441 AND DT 2023 AND VI 110 AND IP 5

Results: 17

A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 564, doi. 10.1111/ejh.13937

By:

Derman, Benjamin A;
Chari, Ajai;
Zonder, Jeffrey;
Major, Ajay;
Stefka, Andrew T;
Jiang, Ken;
Karrison, Theodore;
Jasielec, Jagoda;
Jakubowiak, Andrzej

Publication type:

Article

Luspatercept in combination with recombinant erythropoietin in patients with myelodysplastic syndrome with ring sideroblasts: Stimulating early and late‐stage erythropoiesis.

Published in:

2023

By:

Fattizzo, Bruno;
Versino, Francesco;
Bortolotti, Marta;
Rizzo, Lorenzo;
Riva, Marta;
Barcellini, Wilma

Publication type:

Case Study

Racial and ethnic differences in sickle cell disease within the United States: From demographics to outcomes.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 554, doi. 10.1111/ejh.13936

By:

Pokhrel, Akriti;
Olayemi, Adeniran;
Ogbonda, Stephanie;
Nair, Kiron;
Wang, Jen Chin

Publication type:

Article

Iron chelation therapy.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 490, doi. 10.1111/ejh.13935

By:

Bruzzese, Antonella;
Martino, Enrica Antonia;
Mendicino, Francesco;
Lucia, Eugenio;
Olivito, Virginia;
Bova, Carlo;
Filippelli, Gianfranco;
Capodanno, Isabella;
Neri, Antonino;
Morabito, Fortunato;
Gentile, Massimo;
Vigna, Ernesto

Publication type:

Article

TP53 signal pathway confers potential therapy target in acute myeloid leukemia.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 480, doi. 10.1111/ejh.13934

By:

Zhu, Gelan;
Cai, Jiayi;
Zhong, Hua

Publication type:

Article

Persistent decreased bone marrow CD3+CD56+ T lymphocytes are inversely associated with mature granulocytes in myelodysplastic syndromes.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 575, doi. 10.1111/ejh.13932

By:

Serio, Bianca;
Bertolini, Angela;
Gorrese, Marisa;
Ferrara, Idalucia;
Campana, Annapaola;
Morini, Denise;
Picone, Francesca;
Manzo, Paola;
Selleri, Carmine;
Giudice, Valentina

Publication type:

Article

LP2, a stable lanthipeptide derived from cAng‐(1‐7), exerts myeloprotective action in mice.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 534, doi. 10.1111/ejh.13927

By:

Namsolleck, P.;
Rodgers, K. E.;
Franklin, R.;
Moll, G. N.

Publication type:

Article

The potential etiopathogenetic role and diagnostic utility of CD3+CD56+ regulatory T lymphocytes in Myelodysplastic Syndromes.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 578, doi. 10.1111/ejh.13931

By:

Rubino, Valentina;
Leone, Stefania;
Carriero, Flavia;
Pane, Fabrizio;
Ruggiero, Giuseppina;
Terrazzano, Giuseppe

Publication type:

Article

Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 470, doi. 10.1111/ejh.13930

By:

Mohinani, Ajay;
Patel, Sarah;
Tan, Virginia;
Kartika, Thomas;
Olson, Sven;
DeLoughery, Thomas G.;
Shatzel, Joseph

Publication type:

Article

Platelet kinetics in patients with chronic immune thrombocytopaenia treated with thrombopoietin receptor agonists.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 548, doi. 10.1111/ejh.13929

By:

Pravdic, Zlatko;
Suvajdzic‐Vukovic, Nada;
Djurdjevic, Predrag;
Pantic, Nikola;
Bukumiric, Zoran;
Virijevic, Marijana;
Todorovic‐Tirnanic, Mila;
Thachil, Jecko;
Mitrovic, Mirjana

Publication type:

Article

High risk of infection in 'real‐world' patients receiving ibrutinib, idelalisib or venetoclax for mature B‐cell leukaemia/lymphoma.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 540, doi. 10.1111/ejh.13928

By:

Tey, Amanda;
Schwarer, James;
Raffa, Robert;
Shi, Emily;
Paul, Eldho;
Opat, Stephen;
Dendle, Claire;
Shortt, Jake

Publication type:

Article

Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 527, doi. 10.1111/ejh.13925

By:

Zheng, Xinhui;
Zhang, Haixiao;
Guo, Wenwen;
Cao, YiGeng;
Liu, Xin;
Zhai, WeiHua;
Zhang, Xiaoyu;
Wang, Fengjiao;
Wei, JiaLin;
Yang, DongLin;
Huang, Yong;
Pang, AiMing;
Feng, SiZhou;
Jiang, ErLie;
Han, MingZhe

Publication type:

Article

Global reported impacts of COVID‐19 on lymphoma patients and the emerging clinical management approaches in response to the ongoing pandemic.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 457, doi. 10.1111/ejh.13926

By:

Elliott, Esther K.;
Hensen, Robert;
Haupt, Larisa M.;
Griffiths, Lyn R.

Publication type:

Article

Hematological and genetic profiles of persons with co‐inherited heterozygous β‐thalassemia and supernumerary α‐globin genes.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 510, doi. 10.1111/ejh.13923

By:

Sundaresan, Durga Devi;
Hira, Jasbir Kaur;
Chhabra, Sanjeev;
Trehan, Amita;
Khadwal, Alka Rani;
Malhotra, Pankaj;
Sharma, Prashant;
Das, Reena

Publication type:

Article

Time to pain relief: A randomized controlled trial in the emergency department during vaso‐occlusive episodes in sickle cell disease.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 518, doi. 10.1111/ejh.13924

By:

Tanabe, Paula;
Bosworth, Hayden B.;
Crawford, Regina D.;
Glassberg, Jeffrey;
Miller, Christopher N.;
Paice, Judith A.;
Silva, Susan

Publication type:

Article

RNA‐binding protein PUM2 promotes T‐cell acute lymphoblastic leukemia via competitively binding to RBM5 3′UTR with miR‐28‐5p.

Published in:

European Journal of Haematology, 2023, v. 110, n. 5, p. 498, doi. 10.1111/ejh.13914

By:

Bai, Taomin;
Liu, Na

Publication type:

Article

Issue Information.

Published in:: European Journal of Haematology, 2023, v. 110, n. 5, p. 455, doi. 10.1111/ejh.13795
Publication type:: Article

Works matching IS 09024441 AND DT 2023 AND VI 110 AND IP 5

A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.

Luspatercept in combination with recombinant erythropoietin in patients with myelodysplastic syndrome with ring sideroblasts: Stimulating early and late‐stage erythropoiesis.

Racial and ethnic differences in sickle cell disease within the United States: From demographics to outcomes.

Iron chelation therapy.

TP53 signal pathway confers potential therapy target in acute myeloid leukemia.

Persistent decreased bone marrow CD3<sup>+</sup>CD56<sup>+</sup> T lymphocytes are inversely associated with mature granulocytes in myelodysplastic syndromes.

LP2, a stable lanthipeptide derived from cAng‐(1‐7), exerts myeloprotective action in mice.

The potential etiopathogenetic role and diagnostic utility of CD3<sup>+</sup>CD56<sup>+</sup> regulatory T lymphocytes in Myelodysplastic Syndromes.

Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.

Platelet kinetics in patients with chronic immune thrombocytopaenia treated with thrombopoietin receptor agonists.

High risk of infection in 'real‐world' patients receiving ibrutinib, idelalisib or venetoclax for mature B‐cell leukaemia/lymphoma.

Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation.

Global reported impacts of COVID‐19 on lymphoma patients and the emerging clinical management approaches in response to the ongoing pandemic.

Hematological and genetic profiles of persons with co‐inherited heterozygous β‐thalassemia and supernumerary α‐globin genes.

Time to pain relief: A randomized controlled trial in the emergency department during vaso‐occlusive episodes in sickle cell disease.

RNA‐binding protein PUM2 promotes T‐cell acute lymphoblastic leukemia via competitively binding to RBM5 3′UTR with miR‐28‐5p.

Issue Information.